Selectquote, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NYSE
SelectQuote reports a 12% revenue increase for the six months ended December 31, 2025, driven by its Healthcare Services segment, alongside a significant debt refinancing and ongoing legal challenges.
NYSE
SelectQuote, Inc. reported a wider net loss attributable to common shareholders in Q1 2026, driven by a significant decline in its Senior insurance segment despite growth in Healthcare Services.
NYSE
SelectQuote's Q3 2025 results reveal a revenue increase driven by pharmacy services, overshadowed by a DOJ investigation and a decline in Senior segment performance.
NYSE
SelectQuote, Inc. reports a rise in revenue and income from operations for the quarter ended December 31, 2024, driven by growth in its Senior and Healthcare Services segments.
NYSE
SelectQuote's first quarter of fiscal year 2025 shows a 26% increase in total revenue, primarily driven by a 61% surge in pharmacy revenue, while the company navigates ongoing financial challenges.
NYSE
SelectQuote's Q3 2024 results show revenue growth driven by pharmacy sales, but also reveal ongoing losses and debt restructuring efforts.
NYSE
SelectQuote's second quarter results show a significant revenue increase of 27% year-over-year, driven by growth in pharmacy and commission revenues.